Showing results (281-290 of 496) with videos related to
Sort By:
Pageof 50
Plos Pathogens|February 18, 2021
TLR7 agonist, N6-LS and PGT121 delayed viral rebound in SHIV-infected macaques after antiretroviral therapy interruptionDenise C Hsu, Alexandra Schuetz, Rawiwan Imerbsin, et al.Journal of Virology|April 24, 2021
Correlates of Neutralization against SARS-CoV-2 Variants of Concern by Early Pandemic SeraSamuel J Vidal, Ai-Ris Y Collier, Jingyou Yu, et al.Cell|December 19, 2017
Initiation of Antiviral B Cell Immunity Relies on Innate Signals from Spatially Positioned NKT CellsMauro Gaya, Patricia Barral, Marianne Burbage, et al.Journal of Virology|March 3, 2007
Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and DPeter Abbink, Angelique A C Lemckert, Bonnie A Ewald, et al.Journal of Virology|September 15, 2021
Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2Lisa H Tostanoski, Lisa E Gralinski, David R Martinez, et al.Science (New York, N.Y.)|January 17, 2015
Vaccine-elicited CD4 T cells induce immunopathology after chronic LCMV infectionPablo Penaloza-MacMaster, Daniel L Barber, E John Wherry, et al.Plos One|November 15, 2018
First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1Kathryn E Stephenson, Michael C Keefer, Catherine A Bunce, et al.Biorxiv : the Preprint Server for Biology|January 20, 2025
Contrasting Effects of SARS-CoV-2 Vaccination vs. Infection on Antibody and TCR RepertoiresJasper Braun, Elliot D Hill, Elisa Contreras, et al.Vaccine|October 23, 2023
Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86Ninaad Lasrado, Ai-Ris Y Collier, Nicole P Hachmann, et al.JAMA|March 11, 2021
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19Kathryn E Stephenson, Mathieu Le Gars, Jerald Sadoff, et al.Pageof 50